CSIMarket
 
Establishment Labs Holdings Inc   (ESTA)
Other Ticker:  
 
 
Price: $48.9950 $0.72 1.502%
Day's High: $49.88 Week Perf: 0.54 %
Day's Low: $ 47.50 30 Day Perf: 31.46 %
Volume (M): 247 52 Wk High: $ 79.88
Volume (M$): $ 12,077 52 Wk Avg: $50.33
Open: $47.90 52 Wk Low: $16.96



 Market Capitalization (Millions $) 1,253
 Shares Outstanding (Millions) 26
 Employees 400
 Revenues (TTM) (Millions $) 165
 Net Income (TTM) (Millions $) -79
 Cash Flow (TTM) (Millions $) -26
 Capital Exp. (TTM) (Millions $) 25

Establishment Labs Holdings Inc
Establishment Labs Holdings Inc is a medical technology company that designs, develops, manufactures, and markets breast implants and other medical devices.
The company, which is headquartered in Costa Rica, was founded in 2004 and went public on the NASDAQ stock exchange in 2018.
The company's main product is the Motiva Implant Matrix, a silicone breast implant that is designed to be more natural-looking and feel more like real breast tissue than traditional implants.
The Motiva Implant Matrix uses a proprietary silicone gel formula and a micro-textured surface to create a breast implant that is both safe and aesthetically pleasing.
In addition to its breast implants, Establishment Labs also offers a range of other medical devices, including tissue expanders, surgical instruments, and other surgical solutions.
The company has a global presence, with sales and distribution operations in over 50 countries worldwide.
It has manufacturing facilities in Costa Rica and is also expanding its manufacturing capabilities to other regions, including Europe and the United States.
Overall, Establishment Labs is an innovative medical technology company that is focused on developing and manufacturing safe and effective medical devices for the global market.
Its primary focus on breast implants is unique in the medical device industry and has helped the company carve out a niche in this growing market.


   Company Address: Building B15 and 25 Alajuela 0
   Company Phone Number: 34 2400   Stock Exchange / Ticker: NASDAQ ESTA
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Establishment Labs Holdings Inc

Headline: Establishment Labs Holdings Inc Reports Significant Revenue Contraction in Fiscal Quarter Ending December 31, 2023

Establishment Labs Holdings Inc stock has experienced a significant gain of 11.19% over the last five trading days, extending its year-to-date gains to 65.89%. However, the stock is currently trading on the NASDAQ by -13.8% below its 52-week average. These fluctuations in stock performance are reflective of the company's financial results and operational changes.
The weak demand in the last quarter of 2023 led to increased losses for Establishment Labs Holdings Inc. The shortfall per share rose to $-0.74 from $-0.54, with revenue falling by -26.643% to $32.14 million compared to $43.81 million in the previous year. This decline in revenue is in contrast to the rest of the Medical Equipment & Supplies sector, which saw an improvement in revenue during the same period.

Financing Agreement

Establishment Labs Faces Challenges in the Medical Technology Market

Published Thu, Feb 22 2024 1:00 PM UTC



In an announcement today, Establishment Labs Holdings Inc, a medical technology company specializing in women's health, revealed amendments to its $225 million term loan facility with Oaktree Capital Management, L.P. While the terms for the two tranches are unchanged, the remaining two tranches have undergone modifications. This article will outline the facts surro...

Product Service News

Motiva Implants Storm China: Establishment Labs Deploys Revolutionary Medical Product

Published Mon, Jan 22 2024 1:00 PM UTC

Establishment Labs Holdings Inc. (NASDAQ: ESTA), an international medical technology firm committed to enhancing women's health and wellness, has announced that it has commercially launched its revolutionary product, Motiva Implants, in China. As a leading pioneer in the fields of breast aesthetics and reconstruction, Establishment Labs continues to break new ground with its...

Stock Transactions

Establishment Labs Reveals $50 Million Investment and Strong Financial Performance as Commitment to Women's Health and Wellness Soars

Published Tue, Jan 9 2024 1:06 PM UTC

Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
NEW YORK - Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, primarily in breast aesthetics and reconstruction, has recently made significa...

Product Service News

Revolutionary Motiva Flora Tissue Expander Marks Significant Milestone in Breast Aesthetics and Reconstruction

Published Tue, Jan 2 2024 1:00 PM UTC

Establishment Labs Holdings Inc., a global leader in medical technology, recently achieved a groundbreaking milestone in breast aesthetics and reconstruction. The company proudly announced that the Motiva Flora SmoothSilk Tissue Expander, known for its innovative design and superior performance, was successfully utilized for the first time in the United States. This pivotal ...






 

Establishment Labs Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com